The company participated in Pharmaceutical Africa for the second time, focusing on expanding into East Africa in addition to its traditional West African market. The company specifically promoted its GLP-1 weight-loss API samples and customized sterile injectable formulations. A long-term sample testing agreement was reached with a large pharmaceutical group in Nairobi, Kenya, officially opening the door to the East African pharmaceutical market and achieving full coverage of its African business across both East and West Africa.